Sigilon Therapeutics Inc. (SGTX) Social Stream
SIGILON THERAPEUTICS INC (SGTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SIGILON THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 5 | $48 | $9.001 | $25.8 | $22.47 | 14.82% |
| 2021-11-11 | 5 | $48 | $9 | $25.8 | $22.47 | 14.82% |
| 2021-11-30 | 5 | $48 | $4 | $22.7 | $22.47 | 1.02% |
| 2021-12-15 | 5 | $43 | $4 | $14.5 | $22.47 | -35.47% |
| 2021-12-23 | 5 | $14 | $4 | $7.3 | $22.47 | -67.51% |
| 2022-01-31 | 5 | $14 | $2 | $6.8 | $22.47 | -69.74% |
| 2022-02-10 | 5 | $14 | $2 | $6.4 | $22.47 | -71.52% |
| 2022-03-14 | 5 | $14 | $1.6 | $6.32 | $22.47 | -71.87% |
| 2022-08-05 | 4 | $14 | $0.75 | $6.15 | $22.47 | -72.63% |
| 2022-11-11 | 3 | $7 | $0.5 | $3.166 | $22.47 | -85.91% |
| 2023-05-10 | 1 | $26.007 | $26.007 | $26.007 | $22.47 | 15.74% |
| 2023-05-24 | 1 | $7 | $7 | $7 | $22.47 | -68.85% |
| 2023-06-29 | 3 | $21 | $21 | $21 | $22.47 | -6.54% |
| 2023-07-05 | 3 | $30 | $21 | $25.5 | $22.47 | 13.48% |
The Trend in the Analyst Price Target
Over the past 26 months, SGTX's average price target has gone down $22.
Over the past 34 weeks, SGTX's average upside potential has been 554.35%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-11 | 3 | 2.000 | 0.500 | 1.250 | 0.530 | 135.85% |
| 2022-11-11 | 2 | 7.000 | 0.500 | 3.166 | 0.530 | 497.36% |
| 2023-05-10 | 1 | 26.007 | 26.007 | 26.007 | 6.397 | 306.55% |
| 2023-05-10 | 1 | 2.000 | 2.000 | 2.000 | 0.492 | 306.5% |
| 2023-05-10 | 1 | 26.007 | 26.007 | 26.007 | 0.492 | 5185.98% |
SGTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
SGTX's average broker recommendation rating worsened by 0.53 over the prior 18 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- SGTX has a lower variance in analysts' estimates than -1490.33% of all US stocks.
- In terms of how SIGILON THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 89.85% of that group.
- In the context of Healthcare stocks, SIGILON THERAPEUTICS INC's number of analysts covering the stock is greater than 353.55% of them.
- SIGILON THERAPEUTICS INC's average analyst price target is greater than 405.65% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SIGILON THERAPEUTICS INC are NBTX, PHAR, and GRCL.
View All Top Stocks by Price Target
What is the outlook for SGTX? Use POWR Ratings for clearer insight into price direction.